Insider holders · CIK 0001396814
Pacira BioSciences, Inc. · PCRX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Andreas WickiDirector | — | 950,362 | 950,362 | Dec 14, 2018 · 5:47 pm EST | Form 4 |
| Jonathan SloninChief Medical Officer | 216,384 | — | 216,384 | Aug 18, 2026 · 5:21 pm EDT | Form 4 |
| Kristen WilliamsChief Administrative Officer | 167,062 | — | 167,062 | Jun 5, 2026 · 5:57 pm EDT | Form 4 |
| David M StackCEO and Chairman | 133,683 | 1,208 | 134,891 | Dec 20, 2018 · 4:30 pm EST | Form 4 |
| Lauren RikerSenior Vice President, Finance | 62,284 | — | 62,284 | Jun 12, 2026 · 9:07 pm EDT | Form 4 |
| Gary W PaceDirector | 32,819 | — | 32,819 | Nov 21, 2018 · 4:07 pm EST | Form 4 |
| Laura BregeDirector | 30,120 | — | 30,120 | Jun 12, 2026 · 9:06 pm EDT | Form 4 |
| Mark FroimsonDirector | 26,541 | — | 26,541 | Jun 12, 2026 · 9:06 pm EDT | Form 4 |
| James S ScibettaPresident | 25,118 | — | 25,118 | Jun 7, 2017 · 7:00 pm EDT | Form 4 |
| Christopher ChristieDirector | 23,059 | — | 23,059 | Jun 12, 2026 · 9:07 pm EDT | Form 4 |
| Scott BraunsteinSVP, Strategy & Corp. Dev. | 20,982 | — | 20,982 | Jun 16, 2017 · 8:01 pm EDT | Form 4 |
| Richard ScrantonChief Scientific Officer | 20,101 | — | 20,101 | Jun 15, 2018 · 7:20 pm EDT | Form 4 |
| Michael J. YangDirector | 19,798 | — | 19,798 | Jun 12, 2026 · 9:07 pm EDT | Form 4 |
| Marcelo BigalDirector | 17,798 | — | 17,798 | Jun 12, 2026 · 9:07 pm EDT | Form 4 |
| Alethia YoungDirector | 17,798 | — | 17,798 | Jun 12, 2026 · 9:07 pm EDT | Form 4 |
| James B JonesSVP & Chief Medical Officer | 16,823 | — | 16,823 | Nov 20, 2017 · 6:43 pm EST | Form 4 |
| Roy WinstonChief Clinical Officer | 16,500 | — | 16,500 | Sep 7, 2018 · 4:55 pm EDT | Form 3 |
| Dennis McLoughlinChief Commercial Officer | 14,833 | — | 14,833 | Sep 7, 2018 · 4:58 pm EDT | Form 3 |
| Charles A. Reinhart IIIChief Financial Officer | 13,042 | — | 13,042 | Jun 15, 2018 · 7:19 pm EDT | Form 4 |
| Mark A. KronenfeldDirector | 10,277 | — | 10,277 | Mar 8, 2019 · 4:17 pm EST | Form 4 |
| Taunia MarkvickaSVP, Chief Commercial Officer | 8,579 | 230 | 8,809 | Mar 19, 2015 · 6:59 pm EDT | Form 4 |
| Dennis L WingerDirector | 7,490 | — | 7,490 | Jun 16, 2017 · 8:18 pm EDT | Form 4 |
| Samit HirawatDirector | 6,405 | — | 6,405 | Jun 12, 2026 · 9:07 pm EDT | Form 4 |
| John P Longenecker Ph.D.Director | 5,927 | — | 5,927 | Jun 15, 2018 · 7:16 pm EDT | Form 4 |
| Yvonne GreenstreetDirector | 5,627 | — | 5,627 | Jun 15, 2018 · 7:13 pm EDT | Form 4 |
| Charles Anthony LaranjeiraSVP, Technical Operations | 5,238 | — | 5,238 | Jun 15, 2018 · 7:18 pm EDT | Form 4 |
| Robert J. WeilandChief Commercial Officer | 5,088 | — | 5,088 | Jun 6, 2018 · 8:11 pm EDT | Form 4 |
| Paul J HastingsDirector | 3,529 | — | 3,529 | Jun 15, 2018 · 7:14 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.